SUN3 Inhibitors
SUN3 inhibitors encompass a range of chemical compounds that interfere with the cellular and molecular mechanisms in which SUN3 is implicated. For instance, Paclitaxel and Colchicine operate by altering microtubule dynamics, a critical component of the cytoskeleton, which is linked to the nucleus through the LINC complex involving SUN3. By stabilizing or disrupting microtubules, these compounds can inhibit SUN3's ability to participate in nuclear movement and positioning, which are essential for various cellular functions. Similarly, Latrunculin A and Cytochalasin D target the actin cytoskeleton, another key structural element interacting with SUN3 through the LINC complex. These inhibitors prevent actin polymerization, leading to disorganization of the cytoskeletal network that is essential for transmitting mechanical forces to the nucleus, where SUN3 plays a role. This disruption can lead to a diminished capacity of SUN3 to maintain nuclear architecture and participate in mechanotransduction processes.
Other inhibitors like Blebbistatin, Y-27632, and ML-7 specifically target proteins that regulate actomyosin contractility and actin cytoskeleton organization, such as myosin II and Rho-associated protein kinase (ROCK). By impeding the function of these proteins, these inhibitors can indirectly curtail the mechanical stresses that SUN3 is designed to handle within the LINC complex. Moreover, compounds such as Mitoxantrone and Withaferin A affect chromatin organization and intermediate filament networks, respectively. Mitoxantrone's role as a DNA intercalator and topoisomerase II inhibitor may indirectly influence SUN3's involvement in chromatin organization at the nuclear periphery. Withaferin A, by disrupting vimentin filaments, may alter the structural integrity of the nucleus and, consequently, the functional activity of SUN3. Furthermore, Brefeldin A and Jasplakinolide, by affecting Golgi apparatus function and actin filament stabilization, have the potential to modify the nuclear envelope composition and the actin network, indirectly impacting SUN3's role in nuclear dynamics and structural integrity. Collectively, these inhibitors demonstrate how chemical compounds can attenuate SUN3's function by targeting specific cellular structures and processes that are fundamental to SUN3's role within the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their depolymerization, which can interfere with the mechanical forces exerted by the LINC complex, where SUN3 is a component, potentially disrupting nuclear positioning and mechanotransduction processes regulated by SUN3. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is a myosin II inhibitor that impairs actomyosin contractility. As actomyosin dynamics are crucial for nuclear movement and anchorage through the LINC complex, of which SUN3 is a part, blebbistatin can indirectly reduce SUN3's involvement in these cellular processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that hampers the actin cytoskeleton organization. Since the LINC complex, involving SUN3, connects the cytoskeleton to the nucleoskeleton, ROCK inhibition can diminish SUN3's role in force transmission across the nuclear envelope. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK), which is involved in actin-myosin contraction. By inhibiting MLCK, ML-7 can alter the tension across the LINC complex, where SUN3 is a key element, thus affecting its function in nuclear positioning. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone is a DNA intercalator and topoisomerase II inhibitor that can induce DNA damage and disrupt chromatin organization. As SUN3 is implicated in chromatin organization and attachment to the nuclear envelope, mitoxantrone may indirectly affect SUN3's functional activity. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin and inhibits microtubule polymerization, which can impact microtubule-dependent processes such as nuclear movement within cells, indirectly affecting the role of SUN3 in these processes as part of the LINC complex. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and prevents their polymerization, potentially disrupting the actin cytoskeleton and its connection to the nucleus via the LINC complex, indirectly impacting SUN3's role in nuclear positioning and mechanosignaling. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule dynamics by binding to beta-tubulin. This destabilization can affect the mechanical linkage of the nucleus to the cytoskeleton that involves SUN3, thus influencing its function in maintaining nuclear architecture. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D inhibits actin polymerization and can consequentially alter the cytoskeletal dynamics. This alteration can indirectly affect the functional activity of SUN3 by disrupting the actin-related processes within the LINC complex. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A is known to disrupt vimentin filament organization. Given SUN3's potential interaction with the intermediate filament network through the LINC complex, this disorganization can indirectly impact SUN3's role in nuclear positioning and integrity. | ||||||